Madi Mikidache, Mioulet Valerie, King Donald P, Lomonossoff George P, Montague Nicholas P
The Pirbright Institute, Ash Road, Pirbright GU24 0NF, Surrey, United Kingdom.
Department of Biological Chemistry, John Innes Centre, Colney Lane, Norwich NR4 7UH, United Kingdom.
J Virol Methods. 2015 Aug;220:27-34. doi: 10.1016/j.jviromet.2015.04.002. Epub 2015 Apr 9.
Positive controls are an important component of the quality-control of molecular tests used for diagnosis of livestock diseases. For high consequence agents such as foot-and-mouth disease virus (FMDV), the positive controls required to monitor template extraction, reverse transcription and amplification steps usually consist of material derived from infectious viruses. Therefore, their production is dependent upon the use of high containment facilities and their deployment carries the risks associated with inactivation of "live" FMDV. This paper describes the development of a novel non-infectious positive control that encodes FMDV RNA sequences that are encapsidated within Cowpea mosaic virus (CPMV) particles. This surrogate RNA has been engineered to contain sequences from the 5'UTR and 3D regions of FMDV targeted by many molecular assays (conventional RT-PCR, real-time RT-PCR and RT-LAMP). These sequences were inserted into a movement-deficient version of CPMV RNA-2 which is rescued from cowpea plants (Vigna unguiculota) by inoculation with RNA-1. In order to evaluate the performance of these encapsidated RNAs, nucleic acid prepared from a 10-fold dilution series was tested using a range of molecular assays. Results generated by using the molecular assays confirmed RNA-dependent amplification and the suitability of these particles for use in a range of diagnostic tests. Moreover, these CPMV particles were highly stable for periods of up to 46 days at room temperature and 37 °C. Recombinant CPMV can be used to produce high yields of encapsidated RNAs that can be used as positive and negative controls and standards in molecular assays. This approach provides a surrogate that can be potentially used outside of containment laboratories as an alternative to inactivated infectious virus for molecular diagnostic testing.
阳性对照是用于家畜疾病诊断的分子检测质量控制的重要组成部分。对于口蹄疫病毒(FMDV)等高致病性病原体,监测模板提取、逆转录和扩增步骤所需的阳性对照通常由感染性病毒衍生的材料组成。因此,它们的生产依赖于高防护设施的使用,并且其应用存在与“活”FMDV灭活相关的风险。本文描述了一种新型非感染性阳性对照的开发,该对照编码包装在豇豆花叶病毒(CPMV)颗粒中的FMDV RNA序列。这种替代RNA经过改造,包含许多分子检测(传统RT-PCR、实时RT-PCR和RT-LAMP)所针对的FMDV 5'UTR和3D区域的序列。这些序列被插入到CPMV RNA-2的运动缺陷型版本中,通过接种RNA-1从豇豆植物(Vigna unguiculota)中拯救出来。为了评估这些包装RNA的性能,使用一系列分子检测方法对从10倍稀释系列制备的核酸进行了测试。分子检测产生的结果证实了RNA依赖性扩增以及这些颗粒适用于一系列诊断测试。此外,这些CPMV颗粒在室温下和37℃下长达46天的时间内都非常稳定。重组CPMV可用于高产包装RNA的生产,这些RNA可作为分子检测中的阳性和阴性对照以及标准品。这种方法提供了一种替代物,有可能在防护实验室之外用作分子诊断测试中灭活感染性病毒的替代品。